HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

YSL Beauté

This article was originally published in The Rose Sheet

Executive Summary

Pursuing a "measured, opportunistic entry into skin care" is a key goal for YSL going forward, Gucci Group President/CEO Roger Polet reports during a Dec. 14 analyst presentation in London outlining the recently-appointed chief exec's three-year business plan for the company. Division also will focus on recently launched Cinema fragrance and implement a focused media strategy behind Cinema and "key pillar lines," exec adds. Firm will "continue to innovate with creativity and speed," leveraging its size into a competitive advantage, he notes. Company additionally intends to expand YSL beauty products in the U.S. and Japanese markets, which offer "great opportunities for growth," Polet states. The Americas currently comprise 15% of YSL Beauté sales and Japan 5%, while Europe accounts for 67% of revenues. YSL Beauté is expected to generate 3% compound annual sales growth from 2004-2007, according to Polet...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012694

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel